Journal
TRENDS IN MOLECULAR MEDICINE
Volume 24, Issue 6, Pages 575-589Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2018.04.001
Keywords
-
Funding
- Howard Hughes Medical Institute
- Canadian Institutes of Health Research
- Anna and John J. Sie Foundation postdoctoral fellowship
Ask authors/readers for more resources
A key site of translation control is the phosphorylation of the eukaryotic translation initiation factor 2 alpha (eIF2 alpha), which reduces the rate of GDP to GTP exchange by eIF2B, leading to altered translation. The extent of eIF2 alpha phosphorylation within neurons can alter synaptic plasticity. Phosphorylation of eIF2 alpha is triggered by four stress- responsive kinases, and as such eIF2 alpha is often phosphorylated during neurological perturbations or disease. Moreover, in some cases decreasing eIF2 alpha phosphorylation mitigates neurodegeneration, suggesting that this could be a therapeutic target. Mutations in the gamma subunit of eIF2, the guanine exchange factor eIF2B, an eIF2 alpha phosphatase, or in two eIF2 alpha kinases can cause disease in humans, demonstrating the importance of proper regulation of eIF2 alpha phosphorylation for health.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available